DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ: DMII · FINANCIAL SERVICES · SHELL COMPANIES
$10.20
+0.00% today
Updated 2026-10-28
Market cap
$648.78M
P/E ratio
33.95
P/S ratio
—
EPS (TTM)
$0.30
Dividend yield
—
52W range
$10 – $10
Volume
0.1M
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$10.20
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2024 | 2025 |
|---|---|---|
| Revenue | $0.0B | $0.0B |
| EPS | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.